SCHF vs XBI
Schwab International Equity ETF vs SPDR S&P Biotech ETF
- • SCHF has the lower expense ratio at 0.03% vs 0.35% for XBI.
- • SCHF pays a higher dividend yield (3.11%).
Side-by-side metrics
| Metric | SCHF | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.35% |
Dividend yield Trailing 12-month yield. | 3.11% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $67.70B | $10.92B |
YTD return | 13.62% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.04 | 1.01 |
P/E ratio | 15.76 | — |
Last price | $27.18 | $156.41 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHF top holdings
| 005930.KQ | Samsung Electronics Co Ltd | 2.68% |
| 000660.KQ | SK hynix Inc | 2.10% |
| ASML.AS | ASML Holding NV | 2.10% |
| SHEL.L | Shell PLC | 1.09% |
| NOVN.SW | Novartis AG Registered Shares | 1.05% |
| HSBA.L | HSBC Holdings PLC | 1.01% |
| RY | Royal Bank of Canada | 0.98% |
| AZN.L | AstraZeneca PLC | 0.97% |
| NESN.SW | Nestle SA | 0.92% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About SCHF
SCHF (Schwab International Equity ETF) is Developed-market equities ex-US. Managed by Schwab, the fund carries $67.7B in assets under management, an expense ratio of 0.03%, a dividend yield of 3.11%. Its largest holding is Samsung Electronics Co Ltd (005930.KQ), which represents 2.7% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.